Ronald Richard, Director at Emergent BioSolutions Inc. (EBS), sold 10,000 shares at $17.94 ($179K) on 2008-10-20, disclosed to the SEC on 2008-10-21.
Scheduled sale ($179k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.86 | 1,300 | $23K | 13.0% |
| 2 | $17.87 | 200 | $4K | 2.0% |
| 3 | $17.88 | 1,800 | $32K | 18.0% |
| 4 | $17.89 | 2,100 | $38K | 21.0% |
| 5 | $17.90 | 100 | $2K | 1.0% |
| 6 | $17.94 | 200 |
| $4K |
| 2.0% |
| 7 | $17.95 | 2,200 | $39K | 22.0% |
| 8 | $17.96 | 2,100 | $38K | 21.1% |
| Total | $17.91 avg | 10,000 | $179K | 100% |
| Filing → |
| EBS | SELL | 2020-08-11 | $825K | — | Filing → |
| EBS | SELL | 2020-06-05 | $1.2M | — | Filing → |
| EBS | SELL | 2020-05-06 | $1.3M | — | Filing → |